Treace Medical Concepts TMCI
NASDAQ TMCI
$4.53 -0.10 (-2.16%)
As of: Sep 9, 2026 · 3:59 PM EDT

Treace Medical Concepts (TMCI) EBIT Margin Growth (1y) (2021 - 2026)

Analysis

Treace Medical Concepts (TMCI) EBIT Margin Growth (1y) (2021 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin Growth (1y) (Qtr)
1 Abbott Laboratories 187.42 Bn 182.47 Bn 7.27 Bn -497.00
2 Intuitive Surgical 129.78 Bn 124.69 Bn 1.96 Bn 314.00
3 Medtronic 120.53 Bn 112.33 Bn 6.34 Bn 124.00
4 Stryker 116.28 Bn 112.80 Bn 4.50 Bn 670.00
5 Boston Scientific 69.29 Bn 68.99 Bn 3.85 Bn 546.00
6 Edwards Lifesciences 51.83 Bn 47.68 Bn 1.35 Bn 264.00
7 Alcon 34.36 Bn 32.91 Bn 1.68 Bn -919.00
8 Dexcom 33.17 Bn 31.23 Bn 830.00 Mn 595.00
9 Steris 21.90 Bn 21.43 Bn 684.20 Mn 146.00
10 Treace Medical Concepts 312.82 Mn 267.20 Mn 35.61 Mn 286.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 286.00
Mar 31, 2026 -673.00
Dec 31, 2025 -918.00
Sep 30, 2025 235.00
Jun 30, 2025 1,228.00
Mar 31, 2025 747.00
Dec 31, 2024 1,060.00
Sep 30, 2024 1,015.00
Jun 30, 2024 -1,699.00
Mar 31, 2024 -447.00
Dec 31, 2023 -387.00
Sep 30, 2023 -948.00
Jun 30, 2023 871.00
Mar 31, 2023 -478.00
Dec 31, 2022 971.00
Sep 30, 2022 -898.00
Jun 30, 2022 -2,021.00
Mar 31, 2022 -2,038.00
Dec 31, 2021 -3,182.00
Sep 30, 2021 -2,481.00